FDA approves first ever Friedreich’s ataxia drug treatment
SKYCLARYS was tested and approved by the FDA to treat Friedrich’s ataxia.
Posts tagged as
Matthew Burns
Eight UF research teams awarded MBI grant funding
$744K in grants will support UF research projects and equipment.
Parkinson’s Foundation interviews Dr. Matthew Burns on his patient care and cutting-edge research.
Dr. Burns is tackling Parkinson’s from all angles - from patient care to cutting-edge research in neuroscience.
UF researchers provide insight into the current understanding of Holmes Tremor
Insights could evolve concepts in understanding and treating Holmes Tremor.
